Alkem Laboratories

Alkem is all set to fill the massive gap in accessibility for the treatment of respiratory diseases in India and has further made…

The technology for Diabetic Foot Ulcer (DFU) management has a high scope of preventing amputations in diabetic patients

The causes of high lung disease burden have been identified as underutilisation of diagnostic tools like spirometry insufficient…

The company has launched the tablets in the strength of 800 mg/26.6 mg in the United States, following an approval from the US…

At the end of the inspection, no form 483 was issued, the company said

The US FDA had conducted an inspection of the company’s manufacturing facility from 14-18, June 2021

Alkem has launched Perampil, at 2 mg – Rs 49/strip of 7 tablets, 4 mg – Rs 180/strip of 15 tablets and 6 mg – Rs 300/strip of 15…

Two applications each of Micro Laboratories and Sun Pharma have been deferred by the authority

The Baddi facility was inspected by the US FDA from February 17 to 21, 2020 Alkem Laboratories said the US health regulator has…

Consolidated revenue from operations stood at Rs 2,181.84 crore Alkem Laboratories reported an 89.80 per cent rise in…